What You Should Know:
- Medtronic announced the U.S. Food and
Drug Administration (FDA) approval of the MiniMed™ 770G hybrid insulin pump
system with smartphone connectivity and an expanded age indication to patients
with Type 1 diabetes aged 2 and up ― the lowest age indication by the FDA for
an automated insulin pump system.
- The new
MiniMed 770G system comes with the Guardian™ Sensor 34, the MiniMed™ Mobile app
(compatible with both iPhone and Android), and Roche Accu-Chek®
Read More
Impact of Diabetes Management for Patients, Payers, and Providers| News, Policy, Analysis, Insights - HIT Consultant
One Drop Launches Digital Membership for Whole-Person Approach to Chronic Condition Self-Care
What You Should Know:
- One Drop has expanded its consumer offering beyond
diabetes management with data-driven tools and personalized support for people
living with diabetes, prediabetes, high blood pressure, high cholesterol, or
any combination of these conditions.
One Drop, a New
York City-based provider of digital health solutions
for people living with diabetes and other chronic conditions, today announced
the launch of its Digital
Membership, a new direct-to-consumer subscription
Read More
Medtronic Acquires Smart Insulin Pen Company Companion Medical
What You Should Know:
- Today, Medtronic announced that it will
acquire Companion Medical, the manufacturer of InPen, a smart insulin pen
system paired with an integrated diabetes management app.
- The addition of Companion’s InPen system builds
upon Medtronic's strategic acquisitions of Nutrino and Klue to further
improve overall automated decision-making capabilities and optimizes dosing
decisions using algorithms and AI for patients.
Medtronic,
today announced the
Read More
DreaMed Diabetes Supports Research on Efficacy of Virtual Diabetes Care
What You Should Know:
- DreaMed Diabetes, the developer of personalized, AI-based diabetes management solutions, will participate in a clinical study, led by Jaeb Center for Health Research Foundation, to evaluate the efficacy of virtual treatment for diabetes patients. The research is funded by a grant from The Leona M. and Harry B. Helmsley Charitable Trust.
- DreaMed uses AI-powered technology to seamlessly treat
patients remotely with its virtual diabetes management service by
Read More
Current Health, Dexcom Partner to Deliver Continuous, Remote Glucose Monitoring
What You Should Know:
- Current Health has partnered with Dexcom to add continuous
glucose monitoring (CGM) capabilities to its remote patient monitoring (RPM)
platform – enhancing care and improving outcomes for diabetics.
- Dexcom CGM data will transmit directly into the Current
Health wearable and platform for review by the care management and clinical
teams, improving post-discharge and chronic care of diabetes patients outside
the hospital.
- Through this partnership, Current
Read More
Inovalon Launches FHIR-Based Solution for Health Plan Compliance
What You Should Know:
- Inovalon announced the availability of its Cloud-Based “Consumer Health Gateway” Module, alleviating the need for health plans to build their own Patient Access API to comply with the new requirement of the 21st Century Cures Act.
- The Consumer Health Gateway is a consumer portal allowing the FHIR®-based exchange of a patient’s claims and clinical data securely with authorized third-party applications. It consists of a robust patient consent and authentication
Read More
Why Now’s the Time to Use Connected Health Devices for Diabetes Prevention
It’s no secret that chronic disease remains the leading cause of death worldwide, taking up 90 percent of healthcare spending in the United States. For the last several years, there has been a rise in discussions and research around the promise of connected health devices helping manage and prevent chronic conditions as well as healthcare spending. However, today a number of factors are coming together to make that promise a reality. This includes the improvement of real-world data insights
Read More
State of Connecticut Launches of Livongo for Diabetes Management Program through State Health Plan
What You Should Know:
- Connecticut state Comptroller Kevin Lembo announces the launch of Livongo for Diabetes Management Program through the state health plan to deliver estimated annual savings to the state of approximately $3 million.
- The program, launched in partnership with CVS Caremark and Livongo, is projected to significantly improve health care outcomes for thousands of people with diabetes covered by the state plan by providing them with comprehensive around-the-clock live
Read More
DreaMed Launches Virtual Diabetes Clinic to Help Type-1 Diabetics Control Their Condition in Quarantine
What You Should Know:
- As COVID-19 spreads, DreaMed Diabetes unveils virtual diabetes clinic software to treat people with type 1 diabetes remotely.
- The virtual clinic utilizes Dreamed Diabetes’ AI-powered solution, to improve the insulin management treatment by analyzing the patient’s insulin and glucose data in the platform's algorithm and to remotely advise doctors on treatment.
- According to the CDC people with chronic medical conditions, including diabetes, have a higher risk
Read More
COVID-19: Glooko Offers Free Remote Care to Medical Clinics and People with Diabetes
What You Should Know:
- Glooko today announced that during the COVID-19 pandemic they are taking action to serve the global diabetes community by providing a no-charge remote care solution that provides live patient-to-clinician connectivity.
- To minimize the risk to people with diabetes during this time by broadening access to a remote medical appointment with healthcare providers, Glooko is offering its secure, privacy-protected remote care solution at no charge to medical clinics and
Read More
